Literature DB >> 227764

Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas.

J M Feldman, D S Reintgen, H F Seigler.   

Abstract

Hamster and rat insulinomas were assayed for norepinephrine, dopamine and serotonin concentration and for monoamine oxidase and catechol-o-ethyltransferase (COMT) activity. The concentration of norepinephrine (mean 0.55 mumol/kg, range less than 0.20 to 2.64 mumol/kg) and serotonin (mean 5.22 mucol/kg, rang less than 0.6 to 26.5 mumol/kg) in hamster insulinomas were comparable to previously reported concentrations. Dopamine conentration (mean 0.34 mumol/kg, range less than 0.20 to 0.95 mumol/kg) was only 2 to 2.5% of that reported previously. Monoamine oxidase activity of the hamster and rat insulinomas were comparable to those of normal hamster islets. In contrast, the COMT activity of both insulinomas was much greater than the COMT activity of normal pancreatic islets of both species and was greater than in several other tissues and tumours. The tumour COMT, which was predominantly in the cytosol, was Mg2+ dependent and had a comparable sensitivity to inhibition by tropolone as purified beef-liver COMT. Hamster insulinoma monoamine oxidase was more sensitive than rat insulinoma monoamine oxidase to inhibition by tranylcypromine and deprenyl, while rat insulinoma monoamine oxidase was more sensitive to inhibition by clorgyline and was more heat labile.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227764     DOI: 10.1007/bf01235862

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

Review 1.  Catechol-O-methyl transferase: pharmacological aspects and physiological role.

Authors:  H C Guldberg; C A Marsden
Journal:  Pharmacol Rev       Date:  1975-06       Impact factor: 25.468

2.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

3.  THE INSULIN AND THE ZINC CONTENT OF NORMAL AND DIABETIC PANCREAS.

Authors:  D A Scott; A M Fisher
Journal:  J Clin Invest       Date:  1938-11       Impact factor: 14.808

4.  Mechanisms of catecholamine inactivation by the endocrine pancreas.

Authors:  J M Feldman; B Chapman
Journal:  Diabetes       Date:  1974-09       Impact factor: 9.461

5.  Catechol and indole derivatives in a transplantable islet-cell tumour of the golden hamster.

Authors:  L Cegrell; B Falck; A M Rosengren
Journal:  Acta Physiol Scand       Date:  1969 Sep-Oct

6.  Pancreatic biogenic amines and insulin secretion in health and disease.

Authors:  H E Lebovitz; J M Feldman
Journal:  Fed Proc       Date:  1973-07

7.  Biological properties of a transplantable islet-cell tumor of the golden hamster. II. Insulin content of the tumor and some metabolic characteristics of the tumor-bearing animals.

Authors:  J C Sodoyez; A S Luyckx; P J Lefebvre
Journal:  Diabetes       Date:  1967-06       Impact factor: 9.461

8.  The occurrence of biogenic monoamines in the mammalian endocrine pancreas.

Authors:  L Cegrell
Journal:  Acta Physiol Scand Suppl       Date:  1968

9.  Dopamine in a human islet cell carcinoma metastasis.

Authors:  L Cegrell
Journal:  Acta Pathol Microbiol Scand A       Date:  1970

10.  Microdetermination of catechol-O-methyl transferase in brain.

Authors:  R E McCaman
Journal:  Life Sci       Date:  1965-12       Impact factor: 5.037

View more
  3 in total

1.  Forced immunization.

Authors:  P Jaconello
Journal:  Can Fam Physician       Date:  1979-06       Impact factor: 3.275

2.  Therapy of malignant hamster insulinomas with monoamine precursors.

Authors:  J M Feldman; C Vervaert; C Klatt; H F Seigler
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

3.  5-Hydroxytryptamine transport in cells and secretory granules from a transplantable rat insulinoma.

Authors:  J C Hutton; M Peshavaria; N E Tooke
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.